Chinese patent medicament for treating intractable hypertension

Abstract

The invention relates to a Chinese patent medicament for treating intractable hypertension, which comprises the following Chinese herbal medicaments in part by weight: 50 to 100 parts of seabuckthorn, 80 to 100 parts of wild thyme, 100 to 150 parts of madagascar periwinkle herb, 100 to 150 parts of ganoderma lucidum karst, 150 to 300 parts of black fungus, 80 to 100 parts of emblic root, 50 to 100 parts of salidroside, 50 to 100 parts of devilpepper root, 200 to 300 parts of kudzuvine root, 200 to 300 parts of hawthorn root and 200 to 300 parts of cassia seed. The medicaments are subjected to reasonable compatibility and are complementary in medicinal effects, so the Chinese patent medicament has good effect of reducing blood pressure, can address both symptoms and root causes, is suitable for patients who suffer from senile hypertension, juvenile hypertension, gestational hypertension, salt-sensitive hypertension and the like and particularly has the special and obvious curative effect on patients who suffer from refractory hypertension; and the Chinese patent medicament has the cure rate of 82.7 percent on the refractory hypertension, and has the total cure rate of 68.6 percent, total effectual rate (cure and effect producing) of 89.3 percent and the total effective rate of 100 percent on various kinds of hypertension, and the hypertension does not relapse after being cured.

Description

[0001] technical field [0002] The invention relates to a Chinese patent medicine, in particular to a Chinese patent medicine for treating refractory hypertension. Background technique [0003] Hypertension is a systemic disease caused by the interaction of genetics, environment and other factors. It is a common disease and frequently-occurring disease. The incidence of blood pressure reaches 10-20%, and it is one of the main diseases that endanger human health. [0004] my country is a country with a high incidence of essential hypertension. The 2004 survey on nutrition and health of Chinese residents showed that the prevalence of hypertension among residents over the age of 18 in my country was 18.8%, and it is estimated that the number of patients in the country exceeded 160 million. For this reason, the Ministry of Health of China proposes that October 8th is the National Hypertension Day, requiring residents over the age of 35 to check their blood pressure at least on...

AI Technical Summary

Problems solved by technology

The above-mentioned traditional Chinese medicines for the treatment of high blood pressure pay too much attention to regulation, the effect is slow, the course of treatment is long, and the effect is not ideal

Images